Cervical Cancer Diagnostic Test Market Size, Share, Growth Report 2030

Cervical Cancer Diagnostic Test Market: Overview

The global cervical cancer diagnostic test market accounted for USD 7.45 Billion in 2020 and is expected to reach USD 15.45 Billion by 2028, expanding at a CAGR of 10.4% from 2021 to 2028.

Amongst the types of cancer identified as of now, cervical cancer is the one most prevalent amongst women. Research also states that 90% of the cases of cervical cancer could be attributed to HPV infection. The diagnosis happens through smear screening. The last few years have seen a substantial increase in the population of female smokers. Plus, the frequency of unsafe sex is increasing among teenagers. Therefore, the rate of cervical cancer is increasing in the young population.

Request Free Sample

To know more about this report, request a sample copy.

COVID-19 Impact Analysis:

The outbreak of COVID-19 has escalated the cervical cancer diagnostic tests, more so as the WHO has certified that those suffering from chronic diseases like cancer, and diabetes are more likely to contract Corona. These patients are trying to be doubly sure about the complexities, so that utmost care could be taken amidst the ongoing pandemic. The market for cervical cancer diagnostic tests is not expected to stand still by any means, looking at the situation on the whole.

Growth Factors:

The global cervical cancer diagnostic test market is significantly driven by the rise in the percentage of HPV in the female population. Lack of hygiene and non-awareness of cervical cancer in women is one of the significant factors to boost the need for cervical cancer diagnostic tests in women. According to CDC, more than seven million people acquire HPV in the U.S. Besides, changes in lifestyle, and availability of medical support are expected to propel the market growth. Genetic causes in women are also anticipated to contribute to the market growth in the coming years.

Report Scope:

Test Segment Analysis Preview:

Based on the test, the global market of cervical cancer diagnostic test market is segmented as Pap smear tests, colposcopy, HPV testing, endocervical curettage (ECC), and others. The Pap smear tests accounted for a significant share registering a high CAGR in the past few years. In addition, it is expected to continue dominating in the coming years. Factors such as growing awareness and low test prices are likely to influence commercial growth. The HPV testing segment is anticipated to have a second leading share attributed to rising in incidences of HPV infections in the population.

End-User Segment Analysis Preview:

Based on end-user, the global market of cervical cancer diagnostics test market is trifurcated into hospitals, laboratories, and others. The hospital's segment was the leading segment in 2019. The segment is expected to continue its dominance during the forecast period.

Request Free Sample

To know more about this report, Request For Customization.

Regional Segment Analysis Preview:

North America held a significant share owing rise in awareness and presence of key players. Moreover, developed medical infrastructure offers lucrative opportunities for market development in the near future. The Asia Pacific is the second leading market for cervical cancer diagnostic tests owing to the large population with unmet medical needs. The rise in the geriatric population is one of the major reasons for growth within regional markets.

Request Free Sample

Key Players and Competitive Landscape:

Some of the key players in the cervical caner diagnostic test market include Abbott Laboratories, Becton, Dickinson and Company, Femasys Inc., Hologic Inc., Oncohealth Corp, Quest Diagnostics Inc, QIAGEN and Zilico Ltd.

The Global Cervical Cancer Diagnostic Test Market is segmented into:

By Test:

• Pap Smear Tests
• Colposcopy
• HPV Testing
• Endocervial Cutterage (ECC)
• Others

By End-User:

• Hospitals
• Laboratories
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa